When: Pullback to $900–920 zone with RS vs SPY holding

Then: High-conviction add at validated $906 structural floor; stop $895

SELL - Trim 25-33% of COST position; pause if price closes above 957; accelerate reduction on breakdown below 932

• 47.5x P/E with 4.66 PEG ratio leaves no margin of safety; circular argument that ROE justifies the multiple when market is pricing in perfection
• Visit-rate decline confirmed by top-line growth deceleration: QoQ revenue growth slowed from 3.4% to 1.3%
• Technical setup deteriorating: ATR compressed at 18.30, MACD below signal line, histogram worsening from -0.24 to -1.15, price below 200 SMA, VWMA above price showing aggressive selling on heavy volume
• SCAN Medicare partnership is unproven and contributes essentially zero to FY26 earnings; cannot move needle on $419B market cap
• Real downside scenario is $850-800 (10-15% drawdown), not the $920 July swing low cited by aggressive analyst; multiple compression risk on deteriorating top-line
• Relative-strength break on a defensive name during a market rally day is the most reliable early warning signal in cross-asset risk management

→ vs aggressive: 47.5x P/E is justified by 29% ROE: circular argument—market is pricing in ROE sustainability which is not guaranteed; Walmart 50x P/E in 2000 with decade of multiple compression is cautionary example

→ vs aggressive: Visit-rate is one KPI in isolation: contradicted by revenue QoQ growth math showing same deceleration signal from 3.4% to 1.3%

→ vs aggressive: Technical setup is a coiled spring ready to launch: Bollinger compression resolves in direction of prevailing trend, and moving average structure shows downtrend; MACD histogram deterioration from -0.24 to -1.15 confirms bearish bias

→ vs aggressive: SCAN Medicare partnership is a meaningful catalyst: unproven, untested, and contributes essentially zero to FY26 earnings

→ vs aggressive: 87% prediction market probability for US-China tariff deal reduces risk: prediction markets have been wrong before and flow-through to COGS is not instantaneous

→ vs aggressive: Downside to $920 (2.6% drawdown) is the risk scenario: real downside in a 47.5x P/E with deteriorating top-line is $850-800, a 10-15% drawdown, as multiple compression replaces the technical level argument

→ vs aggressive: Selling on a counter-market down day is selling on noise: relative-strength breakdown on a defensive stock during a market rally day is the single most reliable early warning signal, not noise

REDUCE EXPOSURE MODERATELY - 15-20% trim in two tranches while maintaining 80% of position; re-evaluate adding back only if COST closes above 957 on volume exceeding 1.6 million shares with 50 SMA turning up

• 47.5x P/E multiple represents full valuation with limited margin of safety despite strong fundamentals
• Revenue QoQ decelerated from 3.4% to 1.3% and visit-rate more than halved YoY—converging pattern across income statement and operational KPIs
• Recommend 15-20% trim in two tranches: half now at 945, half on confirmed breakdown below 940 (50 SMA failure)
• Re-entry above 957 on volume > 1.6M shares with 50 SMA turning up—avoid inverted stop structure above entry
• Math favors trim: reduces drawdown by ~80 basis points at 900, captures 85% of rally to 1,094 while keeping exposure
• EPS accelerated to +15.2% YoY, operating margin expanded 24 basis points QoQ, net margin at 3.11%—business still executing
• SCAN partnership adds high-margin vertical; fortress balance sheet provides cushion against multiple compression
• Use trim proceeds for diversification rather than cash—concentration risk is the enemy in uncertain setups
• Technical setup is direction-neutral: 50 SMA declining, price below 200 SMA, MACD below signal, histogram negative 0.24 to negative 1.15
• Neither aggressive nor conservative thesis has high-confidence data support; rational response is disciplined position-sizing

→ vs aggressive: Quality-at-any-price framing ignores that 47.5x multiple already bakes in quality premium; asymmetric downside risk to 850+ is real at premium multiples with decelerating top-line

→ vs aggressive: Volatility compression is direction-neutral; 50 SMA declining, price below 200 SMA, MACD below signal, and histogram deteriorating from negative 0.24 to negative 1.15 indicate distribution, not coiled spring

→ vs aggressive: Downside measured from 945 to 920 is only 2.6%, but multiple compression scenario extends to 850 or lower—not a valid asymmetric argument

→ vs conservative: Walmart 2000 analogy is flawed; Costco's recurring near-100% incremental margin membership revenue is structurally different

→ vs conservative: Visit-rate deceleration hasn't transmitted to Q3 results—EPS +15.2% YoY, operating margin +24bps QoQ, net margin 3.11% show business still executing; treating possible leading indicator as confirmed thesis is premature

→ vs conservative: Stop at 957 above entry 945 is not a stop-loss but a breakout entry—describes a long position with tighter exit, not a trim; framing matters